My research focuses on the development and validation of stability-indicating analytical methodologies for the simultaneous determination of pharmaceutical compounds, with emphasis on structural elucidation of degradation products and the application of chemometric multivariate calibration models — including PLS, ANN, and augmented classical least-squares strategies — as efficient alternatives to conventional chromatographic separation. My work consistently incorporates greenness, blueness, and holistic sustainability assessment frameworks to benchmark newly developed methods against established approaches. I maintain a strong interest in elemental impurity profiling in accordance with ICH guidelines and in the optimization of hyphenated techniques, particularly LC-MS/MS, for high-sensitivity pharmaceutical analysis, reflecting my unique position at the interface of academic research and national pharmaceutical regulation.